Therapeutic antibodies, vaccines and antibodyomes.
The potential for antibodies to act as "magic bullets" for treatment of human disease was recognized a century ago, but its full realization has began to occur only during the last decade. A key to their current success is the ability to make libraries of antibodies/B cells, isolate a single species, and engineer it to be safe, efficacious and of high quality. Despite this progress, major challenges to the effective prevention, diagnosis and treatment of a vast majority of diseases remain. Limited success in the development of effective vaccines against diseases such as AIDS and cancer reflects our incomplete understanding of how antibodies are generated and function. Only a miniscule number of antibodies are characterized out of the universe of antibodies generated by the immune system. Knowledge of antibodyomes-the complete sets of antibodies-could help solve these and other challenges.
Dimitrov
Dimiter S
DS
National Cancer Institute, National Institutes of Health, Frederick, MD, USA. dimiter.dimitrov@nih.gov
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000276:immunology / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D007154:Immune System Diseases / Q000628:therapy; D016247:Information Storage and Retrieval; D009369:Neoplasms / Q000628:therapy; D014612:Vaccines / Q000737:chemistry* / Q000276:immunology / Q000627:therapeutic use*; D015027:Zebrafish / Q000276:immunology
D000911:Antibodies, Monoclonal; D014612:Vaccines
Drugs. 2008;68(18):2557-60
19093698
J Virol. 2006 Jan;80(2):891-9
16378991
Nat Med. 2003 Mar;9(3):269-77
12612576
Viruses. 2009 Dec;1(3):802-17
21994570
Curr Pharm Des. 2007;13(2):203-12
17269928
Pharmacotherapy. 2008 Nov;28(11 Pt 2):31S-41S
18980550
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17121-6
18957538
Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):671-85
16822577
Exp Hematol. 2008 Jul;36(7):755-68
18565392
J Immunol Methods. 2006 Dec 20;317(1-2):21-30
17078964
N Engl J Med. 2006 Sep 7;355(10):1018-28
16908486
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11276-80
18685087
Nat Rev Immunol. 2006 May;6(5):343-57
16622479
Ann Med. 2009;41(5):322-31
19234897
Science. 2009 May 8;324(5928):807-10
19423829
Nature. 1975 Aug 7;256(5517):495-7
1172191
Nat Clin Pract Oncol. 2009 Feb;6(2):93-104
19107109
Biotechnol Annu Rev. 2008;14:191-202
18606364
Biochem Biophys Res Commun. 2009 Sep 18;387(2):387-92
19615335
Curr Opin Pharmacol. 2008 Oct;8(5):620-6
18775515
Eur J Cancer. 2009 Jan;45(1):12-8
19042123
J Pharm Sci. 2008 Jul;97(7):2426-47
17828757
Expert Opin Ther Targets. 2009 Mar;13(3):339-62
19236156
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4337-42
19246393
Nat Rev Microbiol. 2004 Sep;2(9):695-703
15372080
Science. 2009 Apr 10;324(5924):246-51
19251591
Handb Exp Pharmacol. 2008;(181):237-56
18071949
Nat Rev Immunol. 2002 Sep;2(9):706-13
12209139
Biochem Biophys Res Commun. 2009 Dec 18;390(3):404-9
19748484
Nature. 2009 Apr 2;458(7238):636-40
19287373
Drug Saf. 2008;31(6):459-67
18484781
Curr Pharm Biotechnol. 2008 Dec;9(6):423-30
19075682
Expert Opin Biol Ther. 2009 Mar;9(3):341-53
19216623
Curr Top Microbiol Immunol. 2009;333:291-321
19768412
J Immunol Methods. 2003 Dec;283(1-2):17-25
14659896
Science. 2003 Sep 5;301(5638):1374-7
12920303
J Clin Invest. 2006 May;116(5):1167-73
16670757
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
19234466
Curr Drug Targets. 2009 Feb;10(2):131-9
19199909
Cancer Immunol Immunother. 2009 Mar;58(3):317-24
18704409
J Mol Biol. 1991 Dec 5;222(3):581-97
1748994
Rev Recent Clin Trials. 2009 Jan;4(1):34-41
19149761
IDrugs. 2009 Mar;12(3):169-73
19333897
Lancet. 2009 Mar 21;373(9668):1033-40
19304016
Oncologist. 2008 Jun;13(6):725-32
18586928
Curr Opin Drug Discov Devel. 2007 Mar;10(2):219-27
17436557
Nat Rev Drug Discov. 2008 Dec;7(12):1001-12
18989337
N Engl J Med. 2009 Dec 3;361(23):2209-20
19843557
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8
17620608
PLoS Med. 2007 Dec;4(12):e348
18052607
Clin Breast Cancer. 2008 Dec;8 Suppl 4:S157-65
19158036
Science. 1985 Jun 14;228(4705):1315-7
4001944
Curr Opin Immunol. 2008 Aug;20(4):479-85
18577454
Expert Rev Vaccines. 2009 May;8(5):567-76
19397414
Blood Rev. 2009 May;23(3):137-42
18951668
Nature. 1989 Oct 12;341(6242):544-6
2677748
IDrugs. 2009 Feb;12(2):103-8
19204884
Curr Opin Mol Ther. 2003 Apr;5(2):172-9
12772508
Trends Biotechnol. 2008 Dec;26(12):659-67
18977045
Expert Opin Investig Drugs. 2008 Oct;17(10):1553-8
18808314
Mol Immunol. 1999 Oct-Nov;36(15-16):1127-8
10698314
Clin Rev Allergy Immunol. 2010 Apr;38(2-3):82-9
19565360
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20216-21
19875695
Nat Rev Immunol. 2006 Mar;6(3):231-43
16498452
Biotechnol J. 2008 Oct;3(9-10):1185-200
18759247
Cancer Immunol Immunother. 2009 May;58(5):823-30
19198837
Breast Cancer Res Treat. 2008 Dec;112(3):533-43
18188694
Rev Sci Tech. 2007 Apr;26(1):29-48
17633292
Pharmacogenet Genomics. 2009 May;19(5):383-7
19319024
Nat Rev Drug Discov. 2006 Feb;5(2):147-59
16424916
MAbs. 2009 Jul-Aug;1(4):332-8
20073133
Expert Opin Drug Saf. 2009 Mar;8(2):223-35
19243307
Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1537-49
19040329
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20410-5
19074257
J Infect Dis. 2008 Jul 15;198(2):226-33
18522505
Clin Breast Cancer. 2008 Oct;8(5):402-10
18952553
Biochem Biophys Res Commun. 2009 Sep 11;387(1):180-5
19580789
Science. 1989 Dec 8;246(4935):1275-81
2531466
Nat Rev Drug Discov. 2009 Mar;8(3):226-34
19247305
Methods Mol Biol. 2009;525:1-27, xiii
19252861
Curr Opin Immunol. 2008 Aug;20(4):460-70
18656541
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10134-7
1719545
Lancet Neurol. 2008 Dec;7(12):1152-60
19007739